Earnings Evotec’s Turnaround Math Gets Harder as Half-Year Losses Deepen
The numbers landing on Evotec’s desk last Thursday left little room for spin. Germany’s largest independent drug discovery contractor posted first-half revenue of €300.1 million, down 19.2 percent from the...